NEW YORK (GenomeWeb News) - OncoMethylome Sciences said yesterday that it has extended an existing agreement with Schering-Plough to provide methylation testing in clinical trials focused on brain cancer and other cancers.
The agreement applies to OncoMethylome’s methylation assay for the MGMT biomarker, which has been shown to be methylated in a number of cancer types.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.